Variant report
| Variant | nsv1031395 |
|---|---|
| Chromosome Location | chr7:102816661-102868998 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs140134054 | chr7:102827211-102827212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs62480132 | chr7:102827257-102827258 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 3 | rs569178021 | chr7:102827288-102827289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs539746646 | chr7:102827326-102827327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs551320125 | chr7:102827351-102827352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs62480133 | chr7:102827359-102827360 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 7 | rs192497203 | chr7:102827382-102827383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs116117934 | chr7:102827407-102827408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs77619467 | chr7:102827419-102827420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs62480134 | chr7:102827431-102827432 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 11 | rs539736777 | chr7:102827441-102827442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs556416265 | chr7:102827493-102827494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs577966352 | chr7:102827509-102827510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs4265122 | chr7:102827544-102827545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs184676203 | chr7:102827655-102827656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs3987898 | chr7:102827715-102827716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs571319973 | chr7:102827717-102827718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs189196618 | chr7:102827751-102827752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs538738000 | chr7:102827789-102827790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs571982658 | chr7:102827796-102827797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs375751956 | chr7:102827815-102827816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs3987899 | chr7:102827832-102827833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs3987900 | chr7:102827851-102827852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs542290363 | chr7:102827861-102827862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs556971600 | chr7:102827867-102827868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs377042518 | chr7:102827868-102827869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs561002245 | chr7:102827934-102827935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs531325737 | chr7:102828029-102828030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs375903526 | chr7:102828115-102828116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs4336542 | chr7:102828151-102828152 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 31 | rs562751942 | chr7:102828176-102828177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs2909165 | chr7:102828264-102828265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs533388137 | chr7:102828276-102828277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs537597380 | chr7:102828281-102828282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs367635067 | chr7:102828299-102828300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs551655494 | chr7:102828327-102828328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs373704535 | chr7:102828328-102828329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs4266582 | chr7:102828337-102828338 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 39 | rs117020235 | chr7:102828393-102828394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs143151927 | chr7:102828401-102828402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs369864588 | chr7:102828402-102828403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs79984934 | chr7:102828404-102828405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs567637200 | chr7:102828451-102828452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs192569552 | chr7:102828464-102828465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs567722109 | chr7:102828532-102828533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs4727563 | chr7:102828569-102828570 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 47 | rs184838410 | chr7:102828573-102828574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs143067826 | chr7:102828593-102828594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs4729887 | chr7:102828670-102828671 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 50 | rs188436623 | chr7:102828683-102828684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17170743 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Seminomas | 18059402 | CNVD |
| Testicular cancer | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Autism | 19415332 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Malaria | 21533027 | CNVD |
| Melanoma | 18172304 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| head and neck squamous cell carcinoma | 19289630 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Autism | 22495311 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Gastric cancer | 24379144 | CNVD |
| Glioblastoma multiforme | 17002787 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Lissencephaly | 21572526 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Low-grade fibromyxoid sarcoma | 0 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Shwachman-Diamond syndrome | 22934832 | CNVD |
| Colorectal cancer | 19359472 | CNVD |
| Cutaneous malignant melanoma | 17690212 | CNVD |
| Leukemia | 17361228 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Peripheral t-cell lymphoma | 19118030 | CNVD |
| Malignant melanoma | 17690212 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| abortions and stillbirths | 19751515 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Prostate cancer | 16461572 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Burkitt''s lymphoma | 19759907 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Splenic marginal zone lymphoma | 21957467 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Primary central nervous system lymphoma | 21088137 | CNVD |
| Liver carcinoma | 19366792 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Adenocarcinoma | 19607727 | CNVD |
| Multiple myeloma | 16461302 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Emphysema | 19352772 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Medulloblastoma | 17653508 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Autism | 19401682 | CNVD |
| Neuroticism | 17667963 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 19907438 | CNVD |
| Breast cancer | 21364760 | CNVD |
| abnormal development | 18461090 | CNVD |
| Pancreatic cancer | 17952125 | CNVD |
| Glioblastoma multiforme | 21510904 | CNVD |
| Cancer | 20164919 | CNVD |
| Breast cancer | 22522925 | CNVD |
| Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr7:102827200-102827800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
| 2 | chr7:102827400-102827800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 3 | chr7:102827800-102828800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
| 4 | chr7:102828800-102830400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
| 5 | chr7:102829000-102830200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
| 6 | chr7:102835400-102836200 | Enhancers | Liver | Liver |
| 7 | chr7:102835400-102836600 | Enhancers | Hela-S3 | cervix |
| 8 | chr7:102835800-102836200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
| 9 | chr7:102839600-102840400 | Enhancers | K562 | blood |
| 10 | chr7:102850600-102850800 | Weak transcription | Fetal Lung | lung |
| 11 | chr7:102850800-102851000 | Enhancers | Fetal Lung | lung |
| 12 | chr7:102851000-102851400 | Flanking Active TSS | Fetal Lung | lung |
| 13 | chr7:102851200-102851800 | Enhancers | K562 | blood |
| 14 | chr7:102863800-102864000 | Enhancers | GM12878-XiMat | blood |
| 15 | chr7:102864000-102866400 | Weak transcription | GM12878-XiMat | blood |
| 16 | chr7:102865800-102867200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 17 | chr7:102866400-102867000 | Enhancers | GM12878-XiMat | blood |
| 18 | chr7:102867200-102871800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |






